文献速递胸部肿瘤

清扫淋巴结数量对可切除非小细胞肺癌精确分期与长期生存的影响:美国SEER数据库与中国多中心注册数据库的人群研究

Impact of Examined Lymph Node Count on Precise Staging and Long-Term Survival of Resected Non-Small-Cell Lung Cancer: A Population Study of the US SEER Database and a Chinese Multi-Institutional Registry.
PubMed 文献 · J Clin Oncol · 2016-12-28

该研究利用中国多中心注册数据库(n=5,706)与美国SEER数据库(n=38,806)中2001至2008年Ⅰ至ⅢA期可切除非小细胞肺癌数据,分析清扫淋巴结数量与分期迁移及总生存的关系。结果显示清扫淋巴结数量增多与更准确的分期及更好的长期生存相关,并确定16枚为评估淋巴结检查质量或术后预后分层的界值。

要点

  • 清扫淋巴结数量增多与N0至N1、N2分期比例增加及总生存改善相关。
  • 中国注册库中清扫淋巴结数量中位数为15枚,SEER数据库为7枚。
  • 声明淋巴结阴性患者中,清扫淋巴结数量阈值为16枚,并在SEER 2009队列中验证。

核心结论

  • 更多的清扫淋巴结数量与更准确的淋巴结分期及可切除非小细胞肺癌更好的长期生存相关。
  • 作者推荐将16枚清扫淋巴结作为评估淋巴结检查质量或术后预后分层的界值,适用于声明淋巴结阴性的患者。

研究设计与样本

  • 研究分析中国多中心注册数据库(n=5,706)与美国SEER数据库(n=38,806)中2001至2008年Ⅰ至ⅢA期可切除非小细胞肺癌数据。
  • 采用多变量模型分析清扫淋巴结数量与分期迁移及总生存的关系,并用LOWESS平滑拟合平均阳性淋巴结数、比值比与风险比序列,通过Chow检验确定结构断点。
  • 所选界值在SEER 2009队列中进行验证。

主要发现

  • 清扫淋巴结数量分布在中国注册库与SEER数据库间存在差异,中位数分别为15枚与7枚。
  • 随着清扫淋巴结数量增加,两个队列均呈现N0至N1和N2分期的显著比例增加(SEER OR 1.038;中国 OR 1.012;均P < .001)。
  • 控制混杂因素后,清扫淋巴结数量增加与总生存序列改善相关(N0期:SEER HR 0.986;中国 HR 0.981;均P < .001;N1和N2期:SEER HR 0.989;中国 HR 0.984;均P < .001)。
  • 断点分析显示,声明淋巴结阴性患者的清扫淋巴结数量阈值为16枚,推导队列中SEER 2001至2008 HR 0.830、中国 HR 0.738,SEER 2009验证队列 HR 0.837。

关键数值与推荐

  • 声明淋巴结阴性患者的清扫淋巴结数量阈值为16枚(SEER 2001至2008 HR 0.830;中国 HR 0.738;SEER 2009验证队列 HR 0.837)。

临床怎么用

  • 作者推荐将16枚清扫淋巴结作为评估淋巴结检查质量或术后预后分层的界值,适用于声明淋巴结阴性的可切除非小细胞肺癌患者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Purpose We investigated the correlation between the number of examined lymph nodes (ELNs) and correct staging and long-term survival in non-small-cell lung cancer (NSCLC) by using large databases and determined the minimal threshold for the ELN count. Methods Data from a Chinese multi-institutional registry and the US SEER database on stage I to IIIA resected NSCLC (2001 to 2008) were analyzed for the relationship between the ELN count and stage migration and overall survival (OS) by using multivariable models. The series of the mean positive LNs, odds ratios (ORs), and hazard ratios (HRs) were fitted with a LOWESS smoother, and the structural break points were determined by Chow test. The selected cut point was validated with the SEER 2009 cohort. Results Although the distribution of ELN count differed between the Chinese registry (n = 5,706) and the SEER database (n = 38,806; median, 15 versus seven, respectively), both cohorts exhibited significantly proportional increases from N0 to N1 and N2 disease (SEER OR, 1.038; China OR, 1.012; both P < .001) and serial improvements in OS (N0 disease: SEER HR, 0.986; China HR, 0.981; both P < .001; N1 and N2 disease: SEER HR, 0.989; China HR, 0.984; both P < .001) as the ELN count increased after controlling for confounders. Cut point analysis showed a threshold ELN count of 16 in patients with declared node-negative disease, which were examined in the derivation cohorts (SEER 2001 to 2008 HR, 0.830; China HR, 0.738) and validated in the SEER 2009 cohort (HR, 0.837). Conclusion A greater number of ELNs is associated with more-accurate node staging and better long-term survival of resected NSCLC. We recommend 16 ELNs as the cut point for evaluating the quality of LN examination or prognostic stratification postoperatively for patients with declared node-negative disease.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Liang W, He J, Shen Y, et al. Impact of Examined Lymph Node Count on Precise Staging and Long-Term Survival of Resected Non-Small-Cell Lung Cancer: A Population Study of the US SEER Database and a Chinese Multi-Institutional Registry. J Clin Oncol. 2016. PMID: 28029318. doi:10.1200/JCO.2016.67.5140

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。